Our management team

Fernando Andreu CEO

Ole Thastrup CSO and Deputy CEO

Maarten van der Linden Chief Business Officer

Kenneth Graabek Johansen Chief Financial Officer

Henrik Harling Chief Medical Officer

Grith Hagel Chief Operating Officer

Jürgen Kupper Managing director (2cureX GmbH)

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.